Mark E. Tryniski - Jun 1, 2021 Form 4 Insider Report for CONMED Corp (CNMD)

Role: Director
Signature: Sarah M Oliker for Mark E. Tryniski by Power of Attorney
Stock symbol: CNMD
Transactions as of: Jun 1, 2021
Transactions value $: $0
Form type: 4
Date filed: 6/3/2021, 02:31 PM
Next filing: Sep 16, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CNMD	Common Stock	Options Exercise	$0	+1.52K	+3.55%	$0.00	44.4K	Jun 1, 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CNMD	Rsus (restricted Stock Units)	Options Exercise	$0	-1.52K	-100%	$0.00^*	0	Jun 1, 2021	Common Stock	1.52K	$0.00	Direct
transaction	CNMD	Rsus (restricted Stock Units)	Award	$0	+812		$0.00	812	Jun 1, 2021	Common Stock	812	$0.00	Direct	F1
transaction	CNMD	Options To Purchase Common Stock	Award	$0	+865		$0.00	865	Jun 1, 2021	Common Stock	865	$138.45	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period.
F2	The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period.